Home
About
FAQ
History (5)
An RCT of CBT-Telephone for Late-Life GAD
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors.
Impact of hospitalization on blood pressure control in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).
One and four layer acellular bladder matrix for fascial tissue reconstruction.
SPARC Inhibits Metabolic Plasticity in Ovarian Cancer.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SPARC Inhibits Metabolic Plasticity in Ovarian Cancer.
Naczki C, John B, Patel C, Lafferty A, Ghoneum A, Afify H, White M, Davis A, Jin G, Kridel S, Said N. SPARC Inhibits Metabolic Plasticity in Ovarian Cancer. Cancers (Basel). 2018 Oct 16; 10(10).
View in:
PubMed
authors with profiles
Guangxu Jin PhD
Steven J. Kridel PhD
Neveen Said MD, PhD